Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00584207 · ClinicalTrials.gov registry record · Early Phase 1
Radiofrequency Ablation of Uterine Fibroids
A Early Phase 1 study, sponsored by University of California, Davis.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 15
- Enrollment target
NCT00584207 is a Early Phase 1 study that was terminated before completion, run by University of California, Davis. The registered enrollment target is 15 participants.
The verdict
NCT00584207, a Early Phase 1 study, was terminated before completion, sponsored by University of California, Davis.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
This research study is being conducted to evaluate the safety and effectiveness of ablation (destruction) of uterine leiomyomas (fibroids) using electrocautery heating guided by ultrasound. We are doing this to look for a less invasive method of treatment for patients with uterine fibroids. One method that is being used in other areas of the body to treat masses is radiofrequency electrocautery. This method may be performed for the treatment of uterine fibroids by placing a small diameter needle through the wall of the vagina into the fibroid guided by an ultrasound probe. An optional approach is to place the needle through the skin of the abdomen into the fibroid guided by an ultrasound probe. Once the needle is in the fibroid, the electrocautery current is applied and the fibroid is destroyed by heating. This would be done before hysterectomy (removal of the uterus). We are trying to test to see if this type of treatment can be applied to uterine fibroids. We are trying to develop radiofrequency electrocautery as one of the methods to treat fibroids without surgery.
Interventions
- PROCEDURE radiofrequency ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2004-03 |
| Est. Completion | 2008-07 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00584207
The ClinicalTrials.gov registry entry for NCT00584207 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which radiofrequency ablation is the first listed.
NCT00584207 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00584207 about?
NCT00584207 is a clinical study titled "Radiofrequency Ablation of Uterine Fibroids". This research study is being conducted to evaluate the safety and effectiveness of ablation (destruction) of uterine leiomyomas (fibroids) using electrocautery heating guided by ultrasound. We are doing this to look for a less invasive method of treatment for patients with uterine fibroids. One meth...
What is the current status of trial NCT00584207?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 15 participants. The study started on 2004-03. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00584207?
The interventions under investigation include: radiofrequency ablation (PROCEDURE).
Who is sponsoring clinical trial NCT00584207?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.